Joyce J. Lee
CIK 1567830 · View on SEC EDGAR ↗
First SEC filing: Sept. 12, 2019 · Latest: Sept. 12, 2019
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 6, 2013 | ZTS | P | 2,000 | $26.00 | $52,000 | 2,000 Direct | — | Acquired | 191.3% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 8, 2024 | BCPC | Stock Option | Common Stock (1,730) | $143.43 | Feb. 8, 2034 | 1,730 | Acquired |
| Feb. 8, 2023 | BCPC | Stock Option | Common Stock (1,790) | $138.09 | Feb. 8, 2033 | 1,790 | Acquired |
| Feb. 10, 2022 | BCPC | Stock Option | Common Stock (1,747) | $138.07 | Feb. 11, 2032 | 1,747 | Acquired |
| Feb. 11, 2021 | BCPC | Stock Option | Common Stock (2,124) | $119.13 | Feb. 11, 2031 | 2,124 | Acquired |
| Feb. 13, 2020 | BCPC | Stock Option | Common Stock (3) | $111.94 | Feb. 13, 2030 | 3 | Acquired |
| Aug. 15, 2013 | ZTS | Restricted Stock Unit [F1] | Class A Common Stock (6,294) | — | — | 6,294 | Acquired |
| Jan. 31, 2013 | ZTS | Restricted Stock Units [F2] | Class A Common Stock (5,769) | — | — | 5,769 | Acquired |
| Jan. 31, 2013 | ZTS | Stock Option [F1] | Class A Common Stock (21,398) | $26.00 | Jan. 31, 2023 | 21,398 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Sept. 12, 2019 | BCPC | Common Stock | 0 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
ELAN
President, U.S. Pet Health and Commercial Operations| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2021 | $551,000 | — | $1,143,023 | — | $509,124 | — | $976,705 | $3,179,852 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.